News Articles

Read our news stories to stay up to date on our research, the latest discoveries, and other MHIF updates.

CT for PCI Course 2.0
Coronary Artery Disease

Bringing CT for PCI to the U.S.

MHIF's Center for Coronary Artery Disease hosted the CT for PCI Course 2.0

On October 24-25, MHIF's Center for Coronary Artery Disease hosted physicians from all over the world to learn about CT-guided PCI.
Navigating Atrial Fibrillation - Key Insights and Strategies for Better Heart Health
Heart Rhythm

Recapping Our Atrial Fibrillation Education Community Event

MHIF hosted a community education event on October 26, 2024, in St. Paul, MN, where nearly 100 attendees gained insights into atrial fibrillation from expert physician researchers.
wcco interview
Fundraising

Heart 360 Concert for Heart Research in the News

We’re celebrating the Minneapolis Heart Institute Foundation’s recent features on local news sharing details and excitement around Heart 360! Thank you to KSTP, WCCO, FOX 9 and KARE 11 for welcoming our leaders to speak about this important event and help share the importance of heart health and research!
jscai
Coronary Artery Disease

Contributing to Advancing STEMI Heart Attack Care

SCAI’s New Expert Consensus Statement on Primary PCI

The Society for Cardiovascular Angiography & Interventions (SCAI) released a new Expert Consensus Statement on the Management of Patients with STEMI Referred for Primary PCI.

Press Releases

First Enrollment in Research to Evaluate Evidence with SuperSaturated Oxygen (SSO2) Therapy in Reducing Heart Failure and Mortality

Minneapolis Heart Institute Foundation, an independent, world-class cardiovascular research and education organization announced today the first patient enrolled in the SuperSaturated oxygen Comprehensive Observational REgistry (SSCORE) Research Registry. The prospective study is designed to provide further evidence of the efficacy of SuperSaturated Oxygen (SSO2) Therapy, manufactured by Zoll, to reduce heart failure and mortality in patients suffering from left anterior descending ST-elevation myocardial infarction (LAD STEMI) heart attacks, the most serious type of heart attack. 

First U.S. Patient Randomized to CT-Guided PCI in P4 Research Trial Accelerating Innovation with Advanced Cardiovascular Imaging

Minneapolis Heart Institute Foundation® (MHIF) announced the first enrollments in the Precise Procedural and PCI Plan (P4) Research Trial evaluating the potential for advanced cardiovascular imaging to enhance patient care.

Minneapolis Heart Institute Foundation® Announces First Patient Enrolled in VISTA U.S. Study Evaluating Novel Tricuspid Valve Replacement Technology

Minneapolis Heart Institute Foundation® (MHIF) today announced the first enrollment in the VISTA U.S. early feasibility study offering a new transcatheter tricuspid valve technology for severe tricuspid valve regurgitation.

Sign Up For Our Newsletter

Stay up to date on MHIF news, events and the latest information on heart disease treatment and prevention.

CAPTCHA
MHIF Logo

Donate

Contact us

Minneapolis Heart Institute Foundation
920 East 28th Street, Suite 100
Minneapolis, MN 55407

Email: info@mhif.org
Phone: 612-863-3833
Toll Free: 877-800-2729
Fax: 612-863-3801

Connect with us

Follow us on social media for the latest news and updates!

Sign up for our newsletter

Privacy Policy  © Minneapolis Heart Institute Foundation 2024

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.